2016 Grant Recipients

2016 was the second round of grant funding awarded by Avner's Foundation and brings the total grant funding to date to $3.9 million. Our esteemed Scientific Advisory Panel of international and national experts assessed the applications and made their recommendations to the board of Avner’s Foundation, these were unanimously accepted.

Innovation Grant

Therapeutically targeting a solute carrier transporter in the stroma of pancreatic cancer
Development of Novel Agents that Target P-Glycoprotein Resistant Pancreatic Cancer
A novel therapeutic target in pancreatic cancer: Implications for therapy and diagnosis
Utilising a novel predictor to stratify patients with therapy-resistant pancreatic cancer for treatment with CHK inhibitor drugs to improve responses and outcomes

Accelerator Grant

A novel therapeutic target in pancreatic cancer: Implications for therapy and diagnosis
The Australian Pancreatic Cancer organoid Biobank